NIH-funded research R21 grant

Understanding how a gut bacterium causes serious infections and cancer

Official title: Type VII secretion in Streptococcus gallolyticus adherence

Funded at Texas A&m University Health Science Ctr · NIH-10739802 · Data updated 2026-11-12

This study is looking at how a specific bacteria called Streptococcus gallolyticus sticks to the gut and can lead to serious infections and even cancer, with the goal of finding new ways to stop it from causing harm.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionTexas A&m University Health Science Ctr
NIH-funded
Lab location1 site (College Station, United States)
Project startNovember 14, 2022
Project endOctober 31, 2025
Funding year2024
Award (this year)$220,309
NIH project number5R21AI166688-02
Project IDNIH-10739802 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a history of colorectal cancer or those at risk of infections caused by Streptococcus gallolyticus.

Less likely to help

Patients who do not have any gastrointestinal issues or are not at risk for infections related to this bacterium may not benefit from this research.

What this research studies

This research investigates the mechanisms by which the bacterium Streptococcus gallolyticus adheres to the colonic epithelium, which is crucial for its ability to cause severe infections like bacteremia and infective endocarditis, as well as its role in promoting colorectal cancer. The researchers aim to uncover how this bacterium colonizes the gut and affects the integrity of the gut barrier. By studying the type VII secretion system of this bacterium, they hope to identify new ways to prevent its harmful effects on health.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing serious infections and colorectal cancer associated with Streptococcus gallolyticus.

How similar studies have gone: Previous research has shown success in understanding bacterial adherence mechanisms, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Texas A&m University Health Science Ctr
    College Station, United States
    Active

Researchers

  • Principal investigator: Xu, Yi — Texas A&m University Health Science Ctr
  • Study coordinator: Xu, Yi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.